Tortoise Investment Management’s Akero Therapeutics AKRO Stock Holding History

Tortoise Investment Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4	Closed	-$190	–	280
2025 Q3	$190	Buy	+4	New	+$194	﹤0.01%	1312

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tortoise Investment Management's AKRO Position: Q4 2025 in Review

Tortoise Investment Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4 shares — an estimated $190 sold.

Tortoise Investment Management first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $190 in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Tortoise Investment Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Tortoise Investment Management sold 4 Akero Therapeutics shares in Q4 2025, an estimated $190.
Tortoise Investment Management first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
Tortoise Investment Management's Akero Therapeutics position peaked at $190 in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.